PAZOPANIB EG 400 mg, comprimé pelliculé — plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930251379
  • CIP7 3025137
  • CIS 69775438

What the source publishes

Holder
EG LABO - LABORATOIRES EUROGENERICS
Active ingredients
PAZOPANIB, CHLORHYDRATE DE PAZOPANIB
Form
comprimé pelliculé
Package
plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2022-04-20
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930251379
{
  "cis": "69775438",
  "cip7": "3025137",
  "form": "comprimé pelliculé",
  "name": "PAZOPANIB EG 400 mg, comprimé pelliculé — plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)",
  "cip13": "3400930251379",
  "holder": "EG LABO - LABORATOIRES EUROGENERICS",
  "routes": [
    "orale"
  ],
  "holders": [
    "EG LABO - LABORATOIRES EUROGENERICS"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "482.39",
  "authorisedOn": "2022-04-20",
  "compositions": [
    {
      "name": "PAZOPANIB",
      "nature": "FT",
      "strength": "400 mg",
      "linkageNumber": "1",
      "substanceCode": "82348",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE PAZOPANIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "87477",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "481.37",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "PAZOPANIB EG 400 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2025-12-18",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "PAZOPANIB",
    "CHLORHYDRATE DE PAZOPANIB"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930251379"